Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TAINAN, Taiwan, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or the “Company”), a leading supplier and fabless manufacturer of display drivers and other...
-
Reported $4.15 billion (YoY growth of +90%) in preliminary* full-year 2025 global product net sales, inclusive of $1.29 billion in fourth quarter sales VYVGART impact continues with approximately...
-
WISeKey, together with its Subsidiaries, WISeSat and SEALSQ, to Partner with Kaynes Technology’s Satellite Subsidiary KSTPL, to Manufacture Post-Quantum Secure WISeSats Satellites in India and...
-
INFORMATION RÉGLEMENTÉE Publication relative à une notification de transparence Mont-Saint-Guibert (Belgique), le 12 janvier 2026, 7:00h CET / 1:00h ET – Conformément à l'article 14 de la loi du...
-
REGULATED INFORMATION Publication relating to transparency notification Mont-Saint-Guibert (Belgium), January 12, 2026, 7:00 am CET / 1:00 am ET – In accordance with article 14 of the Law of May 2,...
-
On February 4—in Las Vegas, at the National Automobile Dealers Association (NADA) Show — FF will hold a final launch of its first EAI robotics products and begin sales.FX Super One will continue to...
-
Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone...
-
– Reports $156 to $160 Million in Preliminary* Full-Year 2025 U.S. Net Product Sales, a 35% to 38% Increase Compared With Full-Year 2024 – –Total Preliminary* Revenue of $400 to $408 million, a 20%...
-
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate,...
-
Day One today announced the release of preliminary 2025 OJEMDA™ net product revenue and provides 2026 net product revenue guidance